Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

May 13, 2020 / 09:00AM GMT
Release Date Price: $18.76 (+6.05%)
Operator

It is time to start. (Operator Instructions) For question and answer, we will have that session after the presentation. IR head, Mr. Okubo, the floor is yours.

Takashi Okubo
Takeda Pharmaceutical Company Limited - Global Head of IR, Global Finance

[Interpreted] Thank you very much for joining us in this 2019 fiscal year conference call. I appreciate your attendance. I would like to act as the moderator. I am Okubo, Global IR Head.

In today's conference call, I'd like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings.

Page 2 of today's presentation carries important points to be noted. Today's presenters as well as the participants for answering questions. Let me introduce them to you. CEO, President, Christophe Weber; CFO, Costa Saroukos; R&amp

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot